文献速递主动脉疾病

既往开放手术主动脉瘤修复后使用开窗或分支型装置的系統评价与Meta分析

Systematic review and meta-analysis of fenestrated or branched devices after previous open surgical aortic aneurysm repair.
PubMed 文献 · J Vasc Surg · 2023-09-25

该系统评价与Meta分析检索截至2022年11月30日的英文文献,纳入8项回顾性研究共476例既往开放手术修复腹主动脉瘤后接受开窗或分支型腔内修复(F/BEVAR)的患者。汇总显示技术成功率96%、30天死亡率2%、脊髓缺血3%、急性肾损伤6%,随访期间总死亡率5%、主动脉相关死亡率1%、再干预率16%,作者认为围手术期技术成功率高且死亡率和并发症率低。

要点

  • F/BEVAR用于既往开放主动脉瘤修复后,技术成功率估计为96%(95%CI 89%-98%)。
  • 30天死亡率为2%(95%CI 1%-9%),脊髓缺血3%(95%CI 1%-9%),急性肾损伤6%(95%CI 2%-15%)。
  • 随访期间主动脉相关死亡率1%(95%CI 0%-2%),再干预率16%(95%CI 9%-26%)。

核心结论

  • 根据现有文献,既往开放手术修复后行F/BEVAR可能获得高技术成功率和较低的围手术期死亡率和并发症率。
  • 随访期间主动脉相关死亡率为1%,再干预率在F/BEVAR术后的标准范围内。

研究设计与样本

  • 遵循PRISMA声明并在PROSPERO预注册(CRD42022363214)的系统评价与Meta分析。
  • 通过Ovid检索MEDLINE、EMBASE和CENTRAL数据库截至2022年11月30日的英文文献。
  • 纳入2000-2022年报告既往开放手术修复后F/BEVAR结局、样本量≥5例的观察性研究和病例系列。
  • 共纳入8项回顾性研究,476例患者。
  • 使用Newcastle-Ottawa量表和GRADE评估偏倚风险与证据质量,采用比例Meta分析合成数据。

主要发现

  • 在78.3%的病例中,疾病进展为再干预的指征。
  • 技术成功率估计为96%(95%CI 89%-98%;I²=0%;95%预测区间79%-99%)。
  • 30天死亡率为2%(95%CI 1%-9%;I²=0%;95%预测区间0%-28%)。
  • 脊髓缺血率为3%(95%CI 1%-9%;I²=0%;95%预测区间0%-30%),急性肾损伤率为6%(95%CI 2%-15%;I²=0%;95%预测区间1%-40%)。
  • 随访期间总死亡率为5%(95%CI 2%-12%;I²=34%;95%预测区间0%-45%),主动脉相关死亡率为1%(95%CI 0%-2%;I²=0%;95%预测区间0%-3%),再干预率为16%(95%CI 9%-26%;I²=22%;95%预测区间3%-50%)。

临床怎么用

  • 作者认为,根据现有文献,既往开放手术修复后行F/BEVAR可能获得高技术成功率和较低的围手术期死亡率和并发症率。
  • 作者指出随访期间主动脉相关死亡率为1%,再干预率在F/BEVAR术后的标准范围内。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Despite open surgical repair (OSR) of abdominal aortic aneurysms being considered as a durable solution, disease progression and para-anastomotic aneurysms may require further repair, and fenestrated and branched endovascular aneurysm repair (F/BEVAR) may be applied to address these pathologies. The aim of this systematic review was to assess technical success, mortality, and morbidity (acute kidney injury, spinal cord ischemia) at 30 days, and mortality and reintervention rates during the available follow-up, in patients managed with F/BEVAR after previous OSR. METHODS: The PRISMA statement was followed, and the study was pre-registered to the PROSPERO (CRD42022363214). The English literature was searched, via Ovid, using MEDLINE, EMBASE, and CENTRAL databases, through November 30, 2022. Observational studies and case series with ≥5 patients (2000-2022), reporting on F/BEVAR outcomes after OSR, were considered eligible. The Newcastle-Ottawa Scale and GRADE were used to assess the risk of bias and quality of evidence. The primary outcome was technical success, mortality, and morbidity at 30 days. Data on the outcomes of interest were synthesized using proportional meta-analysis. RESULTS: The initial search yielded 1694 articles. Eight retrospective studies (476 patients) were considered eligible. In 78.3% of cases, disease progression set the indication for reintervention. Technical success was estimated at 96% (95% confidence interval [CI], 89%-98%; I2 = 0%; 95% prediction interval [PI], 79%-99%). Thirty-day mortality was 2% (95% CI, 1%-9%; I2 = 0%; 95% PI, 0%-28%). The estimated spinal cord ischemia and acute kidney injury rates were 3% (95% CI, 1%-9%; I2 = 0%; 95% PI, 0%-30%) and 6% (95% CI, 2%-15%; I2 = 0%; 95% PI, 1%-40%), respectively. During follow-up, overall mortality was 5% (95% CI, 2%-12%; I2 = 34%; 95% PI, 0%-45%) and aorta-related mortality was 1% (95% CI, 0%-2%; I2 = 0%; 95% PI, 0%-3%). The rate of reinterventions was 16% (95% CI, 9%-26%; I2 = 22%; 95% PI, 3%-50%). CONCLUSIONS: According to the available literature, F/BEVAR after OSR may be performed with high technical success and low mortality and morbidity during the perioperative period. Follow-up aortic-related mortality was 1%, whereas the reintervention rates were within the standard range following F/BEVAR.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Nana P, Spanos K, Apostolidis G, et al. Systematic review and meta-analysis of fenestrated or branched devices after previous open surgical aortic aneurysm repair. J Vasc Surg. 2023. PMID: 37757916. doi:10.1016/j.jvs.2023.09.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。